339PPalbociclib-fulvestrant (PALBO-FUL) and everolimus...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

339PPalbociclib-fulvestrant (PALBO-FUL) and everolimus -exemestane (EVE-EXE) for second line hormonal treatment (HT) of metastatic breast cancer (MBC) with lobular histology: A propensity score matched analysis of a multicenter ‘real-world’ patients (pts) series

Orlandi, A, Iattoni, E, Pizzuti, L, Fabbri, M A, Botticelli, A, Di Dio, C, Palazzo, A, Garufi, G, Indellicati, G, Alesini, D, Carbognin, L, Paris, I, vaccaro, A, Moscetti, L, Cassano, A, Vici, P, Gian
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz242.034
Date:
October, 2019
File:
PDF, 83 KB
2019
Conversion to is in progress
Conversion to is failed